The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Down 78.7% in July

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a large decline in short interest in July. As of July 15th, there was short interest totalling 2,000 shares, a decline of 78.7% from the June 30th total of 9,400 shares. Based on an average daily volume of 19,500 shares, the short-interest ratio is currently 0.1 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Price Performance

Shares of CGABL traded up $0.12 during midday trading on Friday, reaching $18.66. 2,069 shares of the stock were exchanged, compared to its average volume of 21,179. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52 week low of $15.60 and a 52 week high of $20.75. The company’s 50 day moving average is $18.23 and its two-hundred day moving average is $18.98.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Wednesday, May 1st were paid a $0.2891 dividend. The ex-dividend date was Tuesday, April 30th. This is a positive change from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. This represents a $1.16 dividend on an annualized basis and a yield of 6.20%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.